Second, generating record catheter sales and product utilization in the EP market, third fully launching our new Lynx ™, an irrigated ablation catheter in Europe, fourth, gaining unconditional IDE approval from FDA for the artisan clinical trials, fifth, unveiling the new flexible catheter vascular system, at an important endovascular symposium. Sixth, hiring key senior leadership for US commercial sales, engineering, and training in clinical affairs, and seventh, opening our new European headquarters and clinical education center, to start the base to grow our international business in 2011 and beyond.
In achieving these milestones, I’ve been impressed with the ability of the entire organization, including both new and longtime employees, to adopt a new commercial focus and culture of execution that will be critical to our success. And many highlights in the period reflect that commitment and energy. Operating and financial results for Q4 showed encouraging momentum as well. As noted, we posted strong increases in EP utilization, as we delivered record catheter sales and procedures and impressive growth in both, increasing 24% and 34% over Q4 2009 respectively. In addition, we reduced OpEx by $3 million versus Q4 2009, and cut cash used in operations by $5 million versus Q4 2009; a significant achievement considering the high level of development and other non-selling activities undertaken in the period.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV